Kent Laboratories Inc. is a biotechnology manufacturer based in Bellingham, Washington, specializing in human in vitro diagnostic products based on various forms of polyclonal antibodies. The company has been serving manufacturers, universities, and laboratories since 1974 and offers a product portfolio that includes RID plates and kits, FITC conjugates, immunoglobulins, complement components, acute phase proteins, and control serum. Official company information also states that Kent Laboratories is an FDA-registered facility operating under current Good Manufacturing Practices.
■ Product Portfolio
Vicbio Biotechnology Co., Ltd. provides the full range of Kent Laboratories products.
⇨ Inquire or Order immediately ⇦
●Radial Immunodiffusion (RID) Kits
RID kits include standards, a standard curve reference chart, instructions for use, and three 24-well agar plates. Components are individually sealed, and reference tables are supplied to help convert precipitation ring diameters into concentration values. Kent Laboratories officially lists RID Kits and RID Plates Only as a core product category.
●Acute Phase Proteins
Acute phase proteins are proteins whose plasma concentrations change in a characteristic manner during inflammation. This product category supports related diagnostic and research applications, and is listed by Kent Laboratories as one of its core offerings.
●FITC Conjugates and Immunoglobulin Products
Kent Laboratories offers FITC-conjugated antisera and immunoglobulin-related products, including examples such as IgG-FITC, Albumin-FITC, C1q-FITC, and other conjugates used extensively by researchers and clinical laboratories. The official website lists FITC Conjugates and Immunoglobulins as dedicated product categories.
●Complement Components
Complement component antisera are prepared using purified antigens from normal serum and produced in host animals such as goat, rabbit, sheep, and donkey. According to Kent Laboratories’ product information, these products are purified through affinity-based adsorption approaches to help ensure high specificity and avoid interference in sensitive detection workflows. Product specificity and titer are validated batch by batch.
●Control Serum
Kent Laboratories provides control serum products for titer testing of analytes such as IgG, IgA, IgM, C3 complement, α2-macroglobulin, C3 proactivator precursor, α1-antitrypsin, ceruloplasmin, antithrombin III, transferrin, and haptoglobin. Control Serum is also listed as one of the company’s standard product categories.
■ Product List
| Product name | Cat. # |
| Albumin Low Level | 114531 |
| Alpha-1-Acid-Glycoprotein End Point | 123511 |
| Alpha-1-Antitrypsin End Point | 122511 |
| Alpha-2-Macroglobulin End Point | 124511 |
| Antithrombin III End | 148511 |
| C Reactive Protein | 134511 |
| C-3 (B1C/B1A) End | 105511 |
| C-3 Proactivator (Factor | 106511 |
| C-4 (B1E) End | 109511 |
| C-5 (B1F) End | 110511 |
| C1 Esterase Inhibitor | 135511 |
| C1q End Point | 111511 |
| Ceruloplasmin End Point | 126511 |
| Haptoglobin End Point | 112511 |
| Hemopexin End Point | 149511 |
| IgA End Point | 102511 |
| IgA Low Level | 102531 |
| IgD End Point | 127511 |
| IgG Endpoint and/or | 101511 |
| IgG Low Level | 101531 |
| IgM End Point | 103511 |
| IgM Low Level | 103531 |
| Prealbumin End Point | 154511 |
| Transferrin End Point | 125511 |
| Albumin Low Level | 114431 |
| Alpha-1-Acid Glycoprotein End | 123411 |
| Alpha-1-Antitrypsin End Point | 122411 |
| Alpha-2-Macroglobulin End Point | 124411 |
| Antithrombin III End | 148411 |
| C Reactive Protein | 134411 |
| C-3 Proactivator (Factor | 106411 |
| C-3(B1C/B1A) End Point | 105411 |
| C-4 (B1E) End | 109411 |
| C-5 (B1F) End | 110411 |
| C1 Esterase Inhibitor | 135411 |
| C1q End Point | 111411 |
| Ceruloplasmin End Point | 126411 |
| Haptoglobin End Point | 112411 |
| Hemopexin End Point | 149411 |
| IgA End Point | 102411 |
| IgA Low Level | 102431 |
| IgD End Point | 127411 |
| IgG End Point | 101411 |
| IgG Low Level | 101431 |
| IgM End Point | 103411 |
| IgM Low Level | 103431 |
| Prealbumin End Point | 154411 |
| Transferrin End Point | 125411 |
| Anti Human Alpha-1-Acid | 123002 |
| Anti Human Alpha-1-Antitrypsin | 122002 |
| Anti Human C | 134002 |
| Anti Human Ceruloplasmin | 126002 |
| Anti Human Fibrinogen | 107002 |
| Anti Human Haptoglobin | 112002 |
| Anti Mouse IgG | - |
| Anti Human Albumin FITC | 114202 |
| Anti Human Complement C1q FITC | 111202 |
| Anti Human Complement C-3 (B1C/B1A) FITC | 105202 |
| Anti Human Complement C-3 Proactivator (Factor B) FITC | 106202 |
| Anti Human Complement C-4 (B1E) FITC | 109202 |
| Anti Human Complement C-5 (B1F) FITC | 110202 |
| Anti Human Fibrinogen FITC | 107202 |
| Anti Human IgA FITC (alpha chain specific) | CON-102202 |
| Anti Human IgD FITC | 127202 |
| Anti Human IgE FITC (epsilon chain specific) | 104202 |
| Anti Human IgG FITC (gamma chain specific) | 101202 |
| Anti Human IgM FITC (mu chain specific) | 103202 |
| Anti Human Immunoglobulins (IgG, IgA, IgM) "Polyvalent" FITC | 116202 |
| Anti Human Kappa FITC | 117202 |
| Anti Human Lambda (goat) FITC | 118202 |
| Anti Human Properdin FITC | 108202 |
| Anti Human IgA | 102002 |
| Anti Human IgD | 127002 |
| Anti Human IgE | 104002 |
| Anti Human IgG | 101002 |
| Anti Human IgG | - |
| Anti Human IgG | 128002 |
| Anti Human IgG, | 116002 |
| Anti Human IgM | 103002 |
| Anti Human Kappa | 117002 |
| Anti Human Lambda | 118042 |
| Anti Human C-3 | 119002 |
| Anti Human C-3 | 105002 |
| Anti Human C-3 | 121002 |
| Anti Human C-3 | 106002 |
| Anti Human C-4 | 109002 |
| Anti Human C-5(B1F) | 110002 |
| Anti Human C1 | - |
| Anti Human C1 | 135002 |
| Anti Human C1q | 111002 |
| Anti Human Properdin | 108002 |
| Kentrol Control Serum | - |